Depression, Anxiety and Stress in High School

Depression Clinical Trial

Official title:

Prevalence of Depression, Anxiety and Stress in High School Students: A Survey Study in Western Mexico

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05190107
• Other study ID #: DASSH
• Status: Completed
• Start date: May 1, 2021
• Est. completion date: December 10, 2021

Study information

• Verified date: December 2021
• Source: Instituto Mexicano del Seguro Social
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Background: Social isolation secondary to the pandemic can predispose the population to mental health issues in the future, especially teenagers. The Depression, Anxiety, and Stress Scale (DASS) is a valuable self-report scale since it may be used to screen for anxiety, depression, and stress in one questionnaire. In the last years, it has been observed effective in detecting these symptoms in teenagers. Aims: Identify the prevalence of depression, anxiety, and stress in high school students during the COVID-19 pandemic This is an observational cross-sectional study. For this study, the validated Spanish version of DASS-21 will be used. Qualitative variables will be evaluated through central tendencies, such as mean, standard deviation, and frequencies. The inferential analysis of categorical variables will be performed using the chi-squared test, analysis of variance (ANOVA), or Kruskal Wallis test as appropriate. For quantitative variables, Student's t-test or Mann Whitney U test will be performed depending on their distribution.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 3112
• Est. completion date: December 10, 2021
• Est. primary completion date: November 1, 2021
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 14 Years to 22 Years

Eligibility

Inclusion Criteria:

• Adolescents from 14 to 22 years old.
• That they voluntarily agree to participate, and consent.

Exclusion Criteria:

• Adolescents with depression, anxiety, and stress disorders previously detected
• Patients in psychiatric treatment for depression, anxiety, or stress.
• Participants who don´t consent to participate

Related Conditions & MeSH terms

• Anxiety
• Anxiety Disorders
• Depression
• Depressive Disorder
• Stress

Intervention

Diagnostic Test:
• DASS-21 scale
Each construct consists of 7 questions. The participants must select the answer that better represents their feelings over the last week in each scenario. Each question has a Likert scale of 4 options where 0 represents "did not apply to me" to 3 "applied to me very much.

Locations

Country	Name	City	State
Mexico	Centro Médico Nacional de Occidente	Guadalajara	Jalisco

Sponsors (1)

Lead Sponsor	Collaborator
Instituto Mexicano del Seguro Social

Country where clinical trial is conducted

Mexico, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Depression Score	the Depression, Anxiety and Stress Scale 21 (DASS-21) is an inventory that will be used to identify the presence and intensity of depressive, anxiety and stress. For depression the cutoff scores are: Normal: 0-9, Mild: 10-12, Moderate:13-20, Severe: 21-27, and Extremely severe: 28-42.	Baseline
Primary	Anxiety Score	the Depression, Anxiety and Stress Scale 21 (DASS-21) is an inventory that will be used to identify the presence and intensity of depressive, anxiety and stress. For anxiety the cutoff scores are: Normal: 0-6, Mild: 7-9, Moderate: 10-14, Severe:15-19, and Extremely severe: 20-42.	Baseline
Primary	Stress Score	the Depression, Anxiety and Stress Scale 21 (DASS-21) is an inventory that will be used to identify the presence and intensity of depressive, anxiety and stress. For stress the cutoff scores are: Normal: 0-10, Mild:11-18, Moderate:19-26, Severe: 27-34, and Extremely severe: 35-42.	Baseline